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Objective: Following open-heart surgery, sternal osteomyelitis or infection of the graft
may be a serious complication with high mortality rates. The recommended treat-
ment of an infected graft is its explantation. Because of the poor performance sta-
tus of the patient, this may not always be an option. We report a successful treatment
concept without removal of the infected graft. Methods: The infected ascending aor-
tic graft and the remaining sternum of a critically ill 60-year-old man were covered
with a bilateral pectoralis muscle flap. Results: Postoperatively, the laboratory test val-
ues normalized and the patient was discharged 1 month after the intervention. One
year after surgery, the patient was in good condition and the examination showed no
signs of infection. Conclusion: The thus demonstrated treatment concept with inser-
tion of well-vascularized tissues in combination with a specific antibiotic regime in
our hands proved to be an additional option for the successful management of life-
threatening infections of a sternal osteomyelitis in combination of an infected aortic
graft.
Following open-thoracic surgery, sternal osteomyelitis occurs in 3% to 5%1 and aortic
graft infection in 0.9% to 6% of cases.2 The latter is a rare but serious complication with
mortality rates ranging from 25% to 75%.3 Radical debridement and flap coverage is the
treatment of choice for recalcitrant sternal osteomyelitis,4 whereas the recommended treat-
ment of an infected graft is the explantation.5 On the basis of the poor condition of some of
the patients, graft replacement is associated with high mortality rate (mean = 14%–80%)6
and thus coverage with muscle flaps has been suggested.7 We report the successful therapy
of a case with both, an infected ascending aortic graft and sternal osteomyelitis, without
removal of the graft.
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Figure 1. (a) Preoperative computed tomographic (CT) scan. (b) Postoperative (12 months) CT
scan.
CASE REPORT
A 60-year-old man underwent ascending aorta replacement (Gelweave Valsalva 28,
Vascutek Inc, Glasgow, United Kingdom) and aortic valve repair for a 62-mm aneurysm
(Fig 1a). Because of acute postoperative bleeding, the aortic graft was replaced by a com-
posite graft equipped with a mechanic aortic valve. On postoperative day 19, the patient
developed a systemic inflammatory response syndrome with fever, leukocytosis, and tachy-
cardia. The focus of infection appeared to be a sternal osteomyelitis with delayed healing
of the sternotomy wound, purulent secretion, and perifocal erythema. Blood cultures and
wound swabs were collected before empiric antibiotic therapy with cefepime was started.
Growth of Staphylococcus aureus (sensitive to oxacillin) was found in all specimens. Sternal
debridement was performed and the antibiotic therapy was changed to a combination therapy
(flucloxacillin, rifampicin, and an aminoglycoside). A prosthetic valve endocarditis could
not be excluded, although no typical vegetations were seen by the transesophageal echocar-
diography. After 2 weeks, a second sternal debridement was necessitated because of persis-
tent wound secretion and dehiscence. The wound closure with a VAC (KCI International,
the Netherlands) system was performed by the cardiovascular surgeon and an antibiotic
therapy with only flucloxacillin and rifampicin was continued. Nevertheless, the patient de-
veloped fever and elevated white blood cells counts (Table 1). At this point, the removal and
replacement of the probably infected composite graft was discussed and the plastic surgery
team was consulted. The treatment strategy agreed upon consisted of a radical debridement
and the introduction of well-vascularized tissue around the graft and the sternal wound (1)
to fill dead space and (2) to increase the effect of antibiotics locally.
Table 1. Pre- and postoperative laboratory test values
Preoperative Postoperative, 3 wk Postoperative, 4 mo Postoperative, 1 y
C-reactive protein 181 mg/L 21 mg/L <8 mg/L 10 mg/L
Leukocytes 10.3 × 109/L 7.5 × 109/L 9.1 × 109/L 8.1 × 109/L
Albumin 14 g/L 24 g/L 42 g/L 41 g/L
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The preparation of the pectoralis muscle flaps as a turnover flap on the right side
pedicled on the basis of perforators from the internal mammary artery, and an advancement
flap pedicled on the thoracoacromial vessels on the left side, was followed by a subtotal
sternal debridement. Both flaps were placed in the sternal wound and wrapped around the
graft from both sides. The soft-tissue defect was closed primarily after placing 4 drains.
Operation time was 280 minutes. Swabs taken intraoperatively from the graft showed growth
of Candida albicans but absence of S aureus. Fluconazole was added to the antibiotic regime.
Following this intervention, infectious parameters decreased and hemodynamic and
respiratory parameters had stabilized so that the patient could be extubated and could leave
the intensive care unit 2 days later. One month after radical debridement and wrapping the
bilateral muscle flaps around the graft, the patient was discharged.
Treatment with flucloxacillin 6 × 2 g IV per day and rifampicin 2 × 450 mg po per
day for a total of 6 weeks, initially combined with amikacine 1g IV per day for 2 weeks,
was stopped on the day of discharge.
The conclusion to replace the yeast-infected graft was reached interdisciplinary. For
technical and clinical reasons, such as the size of the needed homograft and the poor
condition of the patient, we decided to treat this patient conservatively with fluconazole
200 mg po per day (dose adapted to renal insufficiency).
The laboratory test values normalized (Table 1) and fluconazole was stopped after
8 months. Blood culture results 1 and 2 months after stopping the antibiotic therapy as well as
1 and 2 months after stopping fluconazole remained sterile. One year after surgery, the patient
was in good condition. The examination showed no signs of infection as well as sufficient
chest stability and good function of the upper extremity with slightly decreased strength
of adduction. Respiratory functions remained unaltered compared with the preoperative
status. The follow-up computed tomographic scan showed perfused muscle flaps around
the ascending aortic graft and no evidence of mediastinal fluid collections (Fig 1b).
DISCUSSION
Sternal osteomyelitis combined with an infection of a vascular graft is a serious complication
with uncertain outcomes. The treatment of sternal osteomyelitis with muscle flaps is a well-
established procedure but the combination with ascending aortic graft infection makes it
more difficult. The best therapy would include the replacement of the graft. However, in a
septic patient with respiratory and hemodynamic instabilities this is often impossible.
In the present case, we decided to cover the ascending aortic graft and the remaining
sternum with well-vascularized tissue—a muscle flap—after a radical debridement. Poten-
tial donor muscle flaps are the rectus abdominis, the latissimus dorsi, or the serratus anterior
flap. The greater omentum flap has also been recommended as a therapy option for a sternal
osteomyelitis. However, in our opinion, one of the big advantages of covering the sternum
with a muscle flap is the avoidance of laparotomy for harvesting of the greater omentum.
Laparotomy poses an additional stress for the patient, especially if he is septic and critically
ill.
Infections of proximal aortic grafts with C albicans are rare and usually associated with
reduced immunocompetence, prolonged antibiotic therapy (like in our patient), extended
parenteral nutrition, or IV drug abuse.8 Lifelong antifungal therapy has been recommended
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for this type of infection, but data supporting the optimal duration of antifungal therapy are
lacking.9
With the procedure described in this article, we outline a treatment option for a combi-
nation of sternal osteomyelitis and infection of the ascending aortic graft without removal
and replacement of the latter. One of the most important aspects in such complicated sit-
uations is an interdisciplinary cooperation of thoracic surgeons with infectious disease
specialists and plastic surgeons, resulting in early diagnosis and optimal treatment—by
antimicrobials as well as operative interventions—of the patient.
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